Salesforce delivered a record quarter and its shares sold off. Revenue of $11.13 billion beat estimates. Adjusted earnings per share of $3.88 blew past the $3.13 consensus - a 50% year-over-year jump. The stock closed at $177.51 and then dropped another $6 in after-hours trading.
This is the mechanics of an inflection entry. The operating results are fine. The narrative has simply become unmanageable.
The old story is still driving the tape
The market has been pricing Salesforce as an AI disruption victim for months. Shares are down roughly 33% year-to-date. Bank of America reinstated an Underperform rating with a $160 price target last week, calling it a "structural reset" - their way of saying the business model itself is being eaten by cheaper, point-solution AI competitors.
Here is what the quarter says: the business model is not being eaten. It is growing 12% in constant currency and printing earnings at a 50% clip.
The headlines worry about AI disruption. The numbers say Salesforce is building its own AI platform, Agentforce, which reached $800 million in annual recurring revenue - up 169% year-over-year. They closed 29,000 Agentforce deals in the last quarter alone, up 50% from the prior quarter. This is not a company being disrupted. This is a company monetizing the disruption it was supposed to fall victim to.
The free cash flow bridge
This is where the thesis gets real. Salesforce generated $12.4 billion in free cash flow last fiscal year - up roughly 31% from the year before. In the fourth quarter alone, free cash flow was $5.3 billion. Management returned 99% of its free cash flow to shareholders, mostly through an aggressive $50 billion share buyback authorization.
That buyback is doing heavy lifting. On a company with a $146 billion market cap, each remaining share captures more of a business that is growing double digits and generating cash at a 30% growth rate. The math compounds: fewer shares, more cash flow per remaining share.
Why the selloff actually helps
The forward P/E is around 13.6 times. The trailing P/E has fallen from its 12-month average of 33 to roughly 23. The PEG ratio (price-to-earnings-growth, which compares the P/E multiple to the earnings growth rate) sits near 0.97 - meaning the stock is trading at roughly one times its growth rate, which is cheap for a software company of this scale.
The market is pricing a company whose earnings power is permanently impaired. But earnings power is up 50%. Free cash flow is up 31%. Revenue is growing double digits. Remaining performance obligations - the backlog of contracted revenue not yet recognized - hit $33.6 billion, up 14% year-over-year. That is a growing pipeline, not a shrinking one.
Selloffs create two kinds of opportunities. One is a broken business that got cheap. The other is a fine business whose valuation got ugly while the numbers kept improving. Salesforce is the second kind.
Target and tripwire
If fiscal 2027 free cash flow comes in near $14 billion - a step up from the $12.4 billion FY26 run rate, supported by continued margin strength - and the multiple rerates from 13.6x toward 18x, still below its own historical average, that puts the stock in the $220–$240 range over the next 12 months.
I can be wrong again. It has really humbled me over the years. But the setup is clean: a double-digit growing software company with surging cash flow, trading at a multiple that implies permanent impairment, while the quarterly results refuse to confirm the thesis against it.
What breaks this: If Q2 guidance shows revenue deceleration below 8–9% constant currency, or if Agentforce ARR growth collapses below 80% year-over-year, the "growth is peaking" narrative gets real evidence and the multiple compression could deepen. Watch the next cRPO print too - if the backlog growth drops below 10%, the pipeline story starts to crack.
Until then, the operating path is getting better while the sentiment is at its ugliest. That is the asymmetry.